Abnormal uterine bleeding: Avoid the rush to hysterectomy

Journal of Family Practice

Volumn 58, Issue 3, 2009, Pages 136-142

  Hill, D Ashley ^a  

^a FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DANAZOL; GESTAGEN; HORMONE; IBUPROFEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ACANTHOSIS NIGRICANS; ACNE; ADENOMYOSIS; BODY MASS; CLINICAL TRIAL; DIAGNOSTIC TEST; DIGESTIVE SYSTEM ULCER; DISEASE EXACERBATION; EDEMA; ENDOMETRIUM ABLATION; ENDOMETRIUM BIOPSY; FEMALE; GALACTORRHEA; GASTROINTESTINAL HEMORRHAGE; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; HYSTERECTOMY; HYSTEROSCOPY; KIDNEY DISEASE; MENOMETRORRHAGIA; MENORRHAGIA; MENSTRUAL CYCLE; MENSTRUATION; METRORRHAGIA; NAUSEA; OVARY POLYCYSTIC DISEASE; OVULATION; PRACTICE GUIDELINE; PREGNANCY TEST; PRIMARY MEDICAL CARE; SHORT SURVEY; SIDE EFFECT; SPOTTING; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY EMBOLIZATION; UTERUS BLEEDING; UTERUS MYOMA; VOICE CHANGE; WEIGHT GAIN;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; CONTRACEPTIVE AGENTS, FEMALE; DANAZOL; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; ENDOMETRIAL ABLATION TECHNIQUES; FEMALE; HUMANS; HYSTERECTOMY; LEVONORGESTREL; MENORRHAGIA; METRORRHAGIA; PRACTICE GUIDELINES AS TOPIC; PREGNANCY TESTS; PROGESTINS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; UTERINE HEMORRHAGE;

EID: 61849157824     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Nicholson WK, Ellison SA, Grason H, et al. Patterns of ambulatory care use for gynecologic conditions: a national study. Am J Obstet Gynecol. 2001;184:523-530.
2. Wilcox A, Baird DD, Dunson D, et al. Natural limits of pregnancy testing in relation to the expected menstrual period. JAMA. 2001;286:1759-1761.
3. Ely JW, Kennedy CM, Clark EC, et al. Abnormal uterine bleeding: a management algorithm. J Am Board Fam Med. 2006;19:590-602.
4. Dijkhuizen F, Mol B, Bralmann H, et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia - a meta-analysis. Cancer. 2000;89:1765-1762.
5. Bayer SR, DeCherney AH. Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA 1993;269:1823-1828.
6. Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand. 2003;82:405-422.
7. Hill DA. Abnormal uterine bleeding. In: Henningsen C, ed. Clinical Guide to Ultrasonography. St. Louis, Mo: Mosby; 2004:173-196.
8. Keshavarz H, Hillis SD, Kieke BA, et al. Hysterectomy surveillance - United States, 1994-1999. MMWR CDC Surveill Summ. 2002;51(SS-5):1-8.
9. Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. An evidence-based guideline for the management of heavy menstrual bleeding. N Z Med J. 1999;112:174-177.
10. Lethaby AE, Cooke I, Rees M. Progesterone or progestogen-ieleasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005;(4):CD002126.
11. Lähteenmäki P, Haukkamaa M, Puolakka J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. BMJ. 1998;316:1122-1126.
12. American College of Obstetricians and Gynecologists (ACOG). Management of anovulatory bleeding. Washington, DC: ACOG; 2000 Mar. 9. ACOG practice bulletin; no. 14.
13. Beaumont H, Augood C, Duckitt K, et al. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007;(3):CD001017.
14. Dawood MY. Nonsteroidal antiinflammatory drugs and reproduction. Am J Obstet Gynecol. 1993;169:1255-1265.
15. Sharp HT. Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol. 2006;108:990-1003.
16. Lethaby A, Shepperd S, Cooke I, et al. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(2):CD000329.
17. Pron G, Bennett J, Common A, et al. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril. 2003;79:120-127.